Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited

2TZ
Current price
2.16 EUR 0 EUR (0.00%)
Last closed 2.2 EUR
Company
ISIN CNE100000924
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Stuttgart Exchange
Capitalization 3 026 615 353 EUR
Yield for 12 month +35.88 %
1Y
3Y
5Y
10Y
15Y
2TZ
21.11.2021 - 28.11.2021

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People's Republic of China. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; and biochemical pharmaceutical products, as well as wholesale and retail sale of medicines. Its products include Suxiao Jiuxin Pills, Jingwanhong Ointment, Biqi Capsules, Shunaoxin Dropping Pills, Zilongjin Tablets, Qingfei Xiaoyan Pills, Huoxiangzhengqi Soft Capsules, Tongmai Yangxin Pills, Weichangan Pills, Qingyan Dropping Pills, Haima Bushen Pills, Angong Niuhuang Pills, Niuhuang Qingxin Pills, Qinggong Shoutao Pills, etc. The company also engages in pharmaceutical commercial logistic services; pharmaceuticals retail; chemical raw materials and preparations; and biomedicine. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was founded in 1981 and is based in Tianjin, the People's Republic of China. Address: Darentang Building, Tianjin, China, 300193

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

14.9833

Dividend Yield

7.5 %

Current Year

+8 207 798 231 EUR

Last Year

+8 234 688 398 EUR

Current Quarter

+1 875 835 408 EUR

Last Quarter

+2 081 907 013 EUR

Current Year

+3 611 841 735 EUR

Last Year

+3 287 843 890 EUR

Current Quarter

+903 022 699 EUR

Last Quarter

+1 073 074 129 EUR

Key Figures 2TZ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 918 279 337 EUR
Operating Margin TTM 14.95 %
PE Ratio 14.9833
Return On Assets TTM 4.49 %
PEG Ratio
Return On Equity TTM 14.26 %
Wall Street Target Price
Revenue TTM 8 084 448 305 EUR
Book Value 8.13 EUR
Revenue Per Share TTM
Dividend Share 1.28 EUR
Quarterly Revenue Growth YOY 2.5 %
Dividend Yield 7.5 %
Gross Profit TTM 2 741 930 494 EUR
Earnings per share 0.15 EUR
Diluted Eps TTM 0.15 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 1.3 %
Profit Margin 11.38 %

Dividend Analytics 2TZ

Dividend growth over 5 years

418 %

Continuous growth

6 years

Payout Ratio 5 years average

7 %

Dividend History 2TZ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.16
Ex Dividend Date 02.07.2024
Forward Annual Dividend Yield 7.24 %
Last Split Factor
Payout Ratio 107.04 %
Last Split Date
Dividend Date

Stock Valuation 2TZ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 14.9833
Forward PE
Enterprise Value Revenue 2.5982
Price Sales TTM 0.3744
Enterprise Value EBITDA 17.5408
Price Book MRQ 2.131

Financials 2TZ

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 2TZ

For 52 weeks

1.35 EUR 2.31 EUR
50 Day MA 1.99 EUR
Shares Short Prior Month
200 Day MA 1.96 EUR
Short Ratio
Shares Short
Short Percent